Melexis (MELE) CMD 2025 summary

Strategic direction and market focus

• Emphasizes antifragility and adaptability, leveraging industry pressures and volatility to strengthen performance, especially in semiconductor and automotive sectors.

• Strategy is anchored on technology leadership, customer intimacy, a fabless model, and system solutions, with a strong focus on innovation and customer-centricity.

• Automotive remains the core market, but significant investments are being made in Robotics, Alternative Mobility, Sustainable World, and Digital Health as new growth vectors.

• China is a critical market, with a local-for-local supply chain strategy, increased customization, and strong local partnerships to meet the demands of Chinese OEMs.

• Geographic expansion includes establishing a legal entity in India and building a strategic footprint in Asia to capture emerging opportunities.

Innovation and product development

• Product launches have accelerated, with 19 planned for 2025 and a growing share of non-automotive innovations, especially in Robotics and Alternative Mobility.

• Introduction of tactile sensors and modules (e.g., Tactaxis) for Robotics and industrial automation, addressing integration challenges and moving up the value chain.

• Focus on advanced sensor and driver technologies, including magnetic, inductive, force sensors, and AI-enabled solutions for automotive and new markets.

• Robust innovation pipeline with 10-15 pre-development and 20-25 development projects annually, balancing automotive and non-automotive R&D.

• Product portfolio expansion includes integrated sensors, signal conditioning ICs, and system modules for diverse applications.

Financial guidance and operational excellence

• Targets high single-digit sales CAGR, 45% gross margin, and 25% EBIT margin, supported by supply chain optimization, product mix, and operating leverage.

• Gross margin improvement initiatives include localization, innovation-driven product mix, and efficient operations.

• EBIT margin improvements through consistent R&D investment (12-14% of sales) and SG&A control.

• Strong balance sheet with increasing free cash flow, low net debt, and active capital allocation for growth, dividends, and share buybacks.

• Inventory levels are expected to decline, improving free cash flow, with product life cycles remaining long and minimizing obsolescence risk.